2Mary E, Short TH, Moriarty HJ. Symptom prevalence, distress, and change over time in patients receiving treatment for lung cancer. Psyco-oncology 2003; 12(7): 694-708.
3Cody M, Nichols S, Brennan C, et al. Psychiatric morbidity in patients with advanced lung cancer. Qual life Res 1993; 2(1):57.
4Osoba D, Murray N, Gelmon K, et al. Quality of life, appetite ,and weight change in patients receiving dose-intensive chemotherapy. Oncology 1994 ;8(4): 61-65.
5Lheureux M,Raherison C, Vernejoux JM,et al. Quality of life in lung cancer: does disclosure of the diagnosis have an impact? Lung Cancer 2004 ;43(2):175-182.
7WHO. The development of the WHO quality of life assessment instrument. Geneva:WHO, 1993:1.
8Bottomley A, Vachalec S, Bjordal K, et al. The development and utilization of the European Organization for Research and Treatment of Cancer Quality of Life Group item bank. Eur J Cancer 2002; 38(12): 1611-1614.
9Buccheri GF, Ferrigno D. Karnofsky and ECOG performance status in lung cancer: equivalence, construct validity, and predictive validity. Lung Cancer 1994; 11 ( suppl 1 ): 87-96.
10Schaafsma J, Osaba D. The Karnofsky performance status scale re-examined: a cross validation with the EORTC-C30.Qual Life Res 1994;3(6):413-424.
7Gokce N,Vita JA,Mc Donnell M,et al.Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients[J].Am J Cardiol,2005,95(2):266–268.
8Lteif A A,Han K,Mather KJ.Obesity,insulin resistance,and the metabolic syndrome:determinants of endothelial dysfunction in whites and blacks[J].Circulation,2005,112(1):32-38.
